CA Patent

CA2824646C — Ferric citrate containing substantially no .beta.-oxidized iron hydroxide

Assigned to Japan Tobacco Inc · Expires 2020-07-14 · 6y expired

What this patent protects

Provided are: a process for producing high-purity ferric citrate that contains substantially no ß-oxidized iron hydroxide; high-purity ferric citrate that contains substantially no ß-oxidized iron hydroxide; and use of the ferric citrate for medical purposes.

USPTO Abstract

Provided are: a process for producing high-purity ferric citrate that contains substantially no ß-oxidized iron hydroxide; high-purity ferric citrate that contains substantially no ß-oxidized iron hydroxide; and use of the ferric citrate for medical purposes.

Drugs covered by this patent

Patent Metadata

Patent number
CA2824646C
Jurisdiction
CA
Classification
—
Expires
2020-07-14
Drug substance claim
No
Drug product claim
No
Assignee
Japan Tobacco Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.